Your browser doesn't support javascript.
loading
Supplementation of vitamins, trace elements and electrolytes in the PEPaNIC Randomised Controlled Trial: Composition and preparation of the prescription.
Eveleens, Renate D; Witjes, Bregje C M; Casaer, Michael P; Vanhorebeek, Ilse; Guerra, Gonzalo Garcia; Veldscholte, Karlien; Hanff, Lidwien M; Cosaert, Katrien; Desmet, Lars; Vlasselaers, Dirk; Maebe, Sofie; Bernard, Britney; Van den Berghe, Greet; Verbruggen, Sascha C A T; Joosten, Koen F M.
Afiliação
  • Eveleens RD; Intensive Care, Department of Paediatrics and Paediatric Surgery, Erasmus Medical Centre - Sophia Children's Hospital, Rotterdam, the Netherlands.
  • Witjes BCM; Department of Clinical Pharmacology and Pharmacy, Erasmus Medical Centre - Sophia Children's Hospital, Rotterdam, the Netherlands.
  • Casaer MP; Department of Cellular and Molecular Medicine, Clinical Division and Laboratory of Intensive Care Medicine, University Hospitals KU Leuven, Leuven, Belgium.
  • Vanhorebeek I; Department of Cellular and Molecular Medicine, Clinical Division and Laboratory of Intensive Care Medicine, University Hospitals KU Leuven, Leuven, Belgium.
  • Guerra GG; Department of Paediatrics, Intensive Care Unit, University Alberta, Stollery Children's Hospital, Edmonton, Canada.
  • Veldscholte K; Intensive Care, Department of Paediatrics and Paediatric Surgery, Erasmus Medical Centre - Sophia Children's Hospital, Rotterdam, the Netherlands.
  • Hanff LM; Department of Pharmacy, Princess Maxima Centre for Paediatric Oncology, Utrecht, the Netherlands.
  • Cosaert K; Department of Pharmacy, University Hospitals KU Leuven, Leuven, Belgium.
  • Desmet L; Department of Cellular and Molecular Medicine, Clinical Division and Laboratory of Intensive Care Medicine, University Hospitals KU Leuven, Leuven, Belgium.
  • Vlasselaers D; Department of Cellular and Molecular Medicine, Clinical Division and Laboratory of Intensive Care Medicine, University Hospitals KU Leuven, Leuven, Belgium.
  • Maebe S; Department of Cellular and Molecular Medicine, Clinical Division and Laboratory of Intensive Care Medicine, University Hospitals KU Leuven, Leuven, Belgium.
  • Bernard B; Department of Paediatrics, Intensive Care Unit, University Alberta, Stollery Children's Hospital, Edmonton, Canada.
  • Van den Berghe G; Department of Cellular and Molecular Medicine, Clinical Division and Laboratory of Intensive Care Medicine, University Hospitals KU Leuven, Leuven, Belgium.
  • Verbruggen SCAT; Intensive Care, Department of Paediatrics and Paediatric Surgery, Erasmus Medical Centre - Sophia Children's Hospital, Rotterdam, the Netherlands.
  • Joosten KFM; Intensive Care, Department of Paediatrics and Paediatric Surgery, Erasmus Medical Centre - Sophia Children's Hospital, Rotterdam, the Netherlands. Electronic address: k.joosten@erasmusmc.nl.
Clin Nutr ESPEN ; 42: 244-251, 2021 04.
Article em En | MEDLINE | ID: mdl-33745587
ABSTRACT
BACKGROUND AND

AIMS:

Following the results of the paediatric early versus late parenteral nutrition in critical illness (PEPaNIC) multicentre, randomised, controlled trial, the new ESPGHAN/ESPEN/ESPR/CSPEN and ESPNIC guidelines recommend to consider withholding parenteral macronutrients for 1 week, while providing micronutrients, in critically ill children if enteral nutrition is insufficient. Critically ill children are suspected to be vulnerable to micronutrient deficiencies due to inadequate enteral nutrition, increased body's demands and excessive losses. Hitherto, micronutrient requirements in PICU are estimated based on recommended daily intakes for healthy children and expert opinion. We aimed to provide an overview of the current practice of micronutrient administration and practical considerations in the three participating centres of the PEPaNIC study, and compare these therapies with the recommendations in the new ESPGHAN/ESPEN/ESPR/CSPEN guidelines.

METHODS:

We describe the current composition and preparation of the prescribed parenteral micronutrients (consisting of vitamins, trace elements and electrolytes) in the three centres (Leuven, Rotterdam and Edmonton) that participated in the PEPaNIC RCT, and compare this per micronutrient with the ESPGHAN/ESPEN/ESPR/CSPEN guidelines recommendations.

RESULTS:

The three centres use a different micronutrient supplementation protocol during the first week of critical illness in children, with substantial differences regarding the amounts administered. Leuven administers commercial vitamins, trace elements and electrolytes in separate infusions both in 4 h. Rotterdam provides commercial vitamins and trace elements simultaneously via 8-h infusion and electrolytes continuously over 24 h. Lastly, Edmonton administers commercial vitamins and institutionally prepared trace elements solutions in 1 h and electrolytes on demand. Comparison with the ESPGHAN/ESPEN/ESPR/CSPEN guidelines yields in differences between the recommendations and the administered amounts, which are most substantial for vitamins.

CONCLUSION:

The practice of intravenous micronutrient administration differs substantially between the three PEPaNIC centres and in comparison with the current guideline recommendations. This deviation is at least partially explained by the inability to provide all recommended amounts with the currently available commercial products and by the lack of strong evidence supporting these recommendations.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oligoelementos Tipo de estudo: Clinical_trials / Guideline Limite: Child / Humans Idioma: En Revista: Clin Nutr ESPEN Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oligoelementos Tipo de estudo: Clinical_trials / Guideline Limite: Child / Humans Idioma: En Revista: Clin Nutr ESPEN Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Holanda